Article

The efficacy of c-di-AMP as an immunopotentiator for inactivated PRV vaccine

2023-07-14

Abstract excerpt

<title>Abstract</title> <p>Pseudorabies is an acute infectious disease caused by pseudorabies virus which bring huge losses to the swine industry. Compared to live vaccine, the inactivated Pseudorabies virus (PRV)vaccine is generally safe, but it could not elicit strong immunity protection as live vaccine. Improve the efficacy of the inactivated vaccines with immunopotentiator is a research hotspot. Viability-ass...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8b54bd20-7bf1-5b00-8496-8a36efc45cd8
DOI: 10.21203/rs.3.rs-3141766/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The efficacy of c-di-AMP as an immunopotentiator for inactivated PRV vaccineDOI 10.21203/rs.3.rs-3141766/v1Read

Recognition of damage-associated molecular patterns related to nucleic acids during inflammation and vaccinationSemantic proximity Read

Kinetically activating nanovaccine mimicking multidimensional immunomodulation of natural infection for broad protection against heterologous viruses in animal modelsSemantic proximity Read

A Tug of War: Pseudorabies Virus and Host Antiviral Innate ImmunitySemantic proximity Read

Mechanism Underlying the Immune Responses of a Sublingual Vaccine for SARS-CoV-2 with RBD Antigen and Adjuvant, Poly(I:C) or AddaS03, in Non-human PrimatesSemantic proximity Read

Recombinant Pseudorabies Virus Usage in Vaccine Development against Swine Infectious DiseaseSemantic proximity Read

Designing of a multi-epitope vaccine candidate against Nipah virus by in silico approach: a putative prophylactic solution for the deadly virusSemantic proximity Read

Progress on innate immune evasion and live attenuated vaccine of pseudorabies virusSemantic proximity Read

A drug candidate for treating adverse reactions caused by pathogenic antibodies inducible by COVID-19 virus and vaccinesSemantic proximity Read

GII.P16-GII.2 Recombinant Norovirus VLPs Polarize Macrophages Into the M1 Phenotype for Th1 Immune ResponsesSemantic proximity Read

Systems Biology behind immunoprotection of both Sheep and Goats after Sungri/96 PPRV vaccinationSemantic proximity Read

Analysis of vaccine-induced immune responses according to the immunization sequences of mRNA and protein vaccinesSemantic proximity Read

TLR7 and RIG-I dual-adjuvant loaded nanoparticles drive broadened and synergistic responses in dendritic cells <i>in vitro</i> and generate unique cellular immune responses in influenza vaccinationSemantic proximity Read